Septerna (SEPN) Change in Acquisitions & Divestments (2024 - 2026)
Septerna (SEPN) recorded quarterly Change in Acquisitions & Divestments of $82.2 million in Q1 2026, up 94.89% quarter-over-quarter from $42.2 million in Q4 2025, and up 81.87% on a YoY basis from $45.2 million in Q1 2025.
Septerna (SEPN) Change in Acquisitions & Divestments (2024 - 2026) Analysis & Trends
Septerna's Change in Acquisitions & Divestments history runs 3 years deep, the most recent figure standing at $82.2 million for Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments rose 81.87% year-over-year to $82.2 million; the TTM figure through Mar 2026 stood at $246.6 million (up 218.27% YoY), while the FY2025 annual figure was $209.6 million, up 549.57% from the prior year.
- Change in Acquisitions & Divestments was $82.2 million for Q1 2026 at Septerna, up from $42.2 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $82.2 million in Q1 2026 to a low of $7.9 million in Q2 2024.
- Historically, Change in Acquisitions & Divestments has averaged $40.5 million across 3 years, with a median of $43.7 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Change in Acquisitions & Divestments surged 697.94% in 2025, then surged 81.87% in 2026.
- A 3-year view of Change in Acquisitions & Divestments shows it stood at $14.9 million in 2024, then surged by 182.56% to $42.2 million in 2025, then soared by 94.89% to $82.2 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $82.2 million (Q1 2026), $42.2 million (Q4 2025), and $59.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82.25 Mn |
| Mar 31, 2026 | 82.25 Mn |
| Dec 31, 2025 | 42.20 Mn |
| Dec 31, 2025 | 42.20 Mn |
| Sep 30, 2025 | 59.08 Mn |
| Sep 30, 2025 | 59.08 Mn |
| Jun 30, 2025 | 63.12 Mn |
| Jun 30, 2025 | 63.12 Mn |
| Mar 31, 2025 | 45.22 Mn |
| Mar 31, 2025 | 45.22 Mn |
| Dec 31, 2024 | 14.94 Mn |
| Dec 31, 2024 | 14.94 Mn |
| Sep 30, 2024 | 9.43 Mn |
| Sep 30, 2024 | 9.43 Mn |
| Jun 30, 2024 | 7.91 Mn |
| Jun 30, 2024 | 7.91 Mn |